Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 4Active not recruiting 4Recruiting 3Terminated 2Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1Prostate Adenocarcinoma 1Pediatric Cancer Patients 1Pancreatic Neoplasms 1Head and Neck Neoplasms 1Chondrosarcoma 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

Docetaxel 21Radiosurgery 19Radiotherapy 17Androgen Antagonists 14Leuprolide 11Goserelin 11bicalutamide 9enzalutamide 8Surveys and Questionnaires 8Prednisone 8Brachytherapy 8Blood Specimen Collection 8Abiraterone Acetate 8acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 7Radiotherapy, Intensity-Modulated 7Multiparametric Magnetic Resonance Imaging 7Gonadotropin-Releasing Hormone 7Triptorelin Pamoate 6pembrolizumab 4cabazitaxel 4abiraterone 4Standard of Care 4Positron Emission Tomography Computed Tomography 4Metformin 4Heavy Ion Radiotherapy 4Exercise 4Estramustine 4luprolide acetate gel depot 3darolutamide 3Watchful Waiting 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Prostatic Neoplasms × Proton Therapy × Clear all
NCT02040610 2019-04-05

Hypofractionated Image Guided Proton Therapy for Low andIntermediate Risk Prostate Cancer

Provision Center for Proton Therapy

Phase NA Unknown
235 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡